The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors

Journal of Surgical Oncology

Volumn 106, Issue 7, 2012, Pages 811-815

  Brougham, Nicholas D L S ^a,b   Dennett, Elizabeth R ^b   Cameron, Rujuta ^a   Tan, Swee T ^a,b,c  

^a HUTT HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c GILLIES MCINDOE RESEARCH INSTITUTE   (New Zealand)

Author keywords

cutaneous; incidence; metastasis; risk factors; squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER INCIDENCE; CANCER SURGERY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; LYMPHOID TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERINEURAL INVASION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK FACTOR; SKIN CARCINOMA; SUBCUTANEOUS TISSUE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84868338623     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23155     Document Type: Article

References (37)

1. Brougham NDL, Tan ST, Dennett ER:, Changing incidence of non-melanoma skin cancer in New Zealand. ANZJS 2011; 81: 633-636.
2. Brougham ND, Dennett ER, Tan ST:, Non-melanoma skin cancers in New Zealand-a neglected problem. NZ Med J 2010; 123: 59-65.
3. Staples MP, Elwood M, Burton RC, et al.: Non-melanoma skin cancer in Australia: The 2002 national survey and trends since 1985. Med J Aust 2006; 184: 6-10.
4. Holme SA, Malinovszky K, Roberts DL:, Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143: 1224-1229.
5. Karagas MR, Greenberg ER, Spencer SK, et al.: Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999; 81: 555-559.
6. Lansbury L, Leonardi-Bee J, Perkins W, et al.: Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010; CD007869.
7. Bath-Hextall F, Leonardi-Bee J, Somchand N, et al.: Interventions for preventing non-melanoma skin cancers in high-risk groups. Cochrane Database Syst Rev 2007; CD005414.
8. Girschik J, Fritschi L, Threlfall T, et al.: Deaths from non-melanoma skin cancer in Western Australia. Cancer Causes Control 2008; 19: 879-885.
9. Simcock JW:, Managing the skin cancer surge. NZ Med J 2010; 123.
10. Epstein E, Epstein NN, Bragg K, et al.: Metastases from squamous cell carcinomas of the skin. Arch Dermatol 1968; 97: 245-251.
11. Lund HZ:, How often does squamous cell carcinoma of the skin metastasize ? Arch Dermatol 1965; 92: 635-637.
12. Katz AD, Urbach F, Lilienfeld AM:, The frequency and risk of metastases in squamous-cell carcinoma of the skin. Cancer 1957; 10: 1162-1166.
13. Dinehart SM, Pollack SV:, Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989; 21: 241-248.
14. Tavin E, Persky M:, Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996; 106: 156-158.
15. Chuang TY, Popescu NA, Su WP, et al.: Squamous cell carcinoma. A population-based incidence study in Rochester, Minn. Arch Dermatol 1990; 126: 185-188.
16. Non-melanoma skin cancer: Guidelines for treatment and management in Australia. Canberra: National Health and Medical Research Council; 2003; 119.
17. Kovach BT, Stasko T:, Skin cancer after transplantation. Transplant Rev (Orlando) 2009; 23: 178-189.
18. Moore BA, Weber RS, Prieto V, et al.: Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005; 115: 1561-1567.
19. Dinehart SM, Peterson S:, Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005; 31: 1379-1384.
20. Jensen P, Hansen S, Moller B, et al.: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-186.
21. Rowe DE, Carroll RJ, Day CL Jr:, Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.[see comment]. J Am Acad Dermatol 1992; 26: 976-990.
22. Kraus DH, Carew JF, Harrison LB:, Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124: 582-587.
23. Farasat S, Yu SS, Neel VA, et al.: A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: Creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011; 64: 1051-1059.
24. Cox DR:, Regression models and life-tables. J Roy Stat Soc 1972; 34: 187-220.
25. O'Brien CJ, McNeil EB, McMahon JD, et al.: Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002; 24: 417-422.
26. Veness MJ, Palme CE, Morgan GJ:, High-risk cutaneous squamous cell carcinoma of the head and neck: Results from 266 treated patients with metastatic lymph node disease. Cancer 2006; 106: 2389-2396.
27. McCombe D, MacGill K, Ainslie J, et al.: Squamous cell carcinoma of the lip: A retrospective review of the Peter MacCallum Cancer Institute experience 1979-88. ANZJS 2000; 70: 358-361.
28. Breuninger H, Black B, Rassner G:, Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94: 624-627.
29. Cherpelis BS, Marcusen C, Lang PG:, Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 2002; 28: 268-273.
30. Goepfert H, Dichtel WJ, Medina JE, et al.: Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148: 542-547.
31. Brantsch KD, Meisner C, Schonfisch B, et al.: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: A prospective study. Lancet Oncol 2008; 9: 713-720.
32. Basal cell carcinoma, squamous cell carcinoma (and related lesions)-a guide to clinical management in Australia. Sydney: Cancer Council Australia and Australian Cancer Network, 2008.
33. Motley R, Kersey P, Lawrence C, et al.: Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg 2003; 56: 85-91.
34. Renzi C, Caggiati A, Mannooranparampil TJ, et al.: Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: Case series and review of the literature. Eur J Surg Oncol 2007; 33: 364-369.
35. Ross AS, Schmults CD:, Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature. Dermatol Surg 2006; 32: 1309-1321.
36. Rastrelli M, Soteldo J, Zonta M, et al.: Sentinel node biopsy for high-risk cutaneous nonanogenital squamous cell carcinoma: A preliminary result. Eur Surg Res 2010; 44: 204-208.
37. Murali R, Haydu LE, Quinn MJ, et al.: Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Ann Surg 2012; 255: 128-133.